X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF IMMUNOTHERAPY

期刊標題檢索 J IMMUNOTHER 最新評論: Hello, do all authors need to click on that confirmation email for the... (2023-12-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF IMMUNOTHERAPY]您好,您是該頁面的第 24970 位訪客。

期刊簡介
期刊名稱JOURNAL OF IMMUNOTHERAPY JOURNAL OF IMMUNOTHERAPY
LetPub Score
7.3
50 ratings
Rate

Reputation
8.8

Influence
6.2

Speed
7.0

期刊簡稱J IMMUNOTHER
ISSN1524-9557
E-ISSN1537-4513
h-index89
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.901.2630.745
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q293 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology and Allergy
Q285 / 233
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Cancer Research
Q288 / 230
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology
Q2100 / 236

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic. JIT contains full-length articles, review articles, and short communications.
官方網站http://journals.lww.com/immunotherapy-journal/pages/default.aspx
在線稿件提交https://www.editorialmanager.com/JIT
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1997
每年文章數44每年文章數趨勢
黃金OA百分比25.85%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ399/181
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ281/189
ONCOLOGYSCIEQ2129/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1524-9557%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【JOURNAL OF IMMUNOTHERAPY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    ImmunityH-index: 355

    CiteScore: 49.40
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology320058
    JOURNAL OF IMMUNOLOGY156702
    Immunity107949
    Cellular & Molecular Immunology107444
    Vaccine104782
    JOURNAL OF EXPERIMENTAL MEDICINE99467
    MICROBIAL PATHOGENESIS94251
    MOLECULAR IMMUNOLOGY91067
    INFLAMMATION89750
    BRAIN BEHAVIOR AND IMMUNITY84747
  •  

    JOURNAL OF IMMUNOTHERAPY JOURNAL OF IMMUNOTHERAPY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [JOURNAL OF IMMUNOTHERAPY] 的評論撰寫評論
作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 18:43:07 評論於
Hello, do all authors need to click on that confirmation email for the manuscript?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 18:14:28 評論於
Hello, do all authors need to click on the manuscript confirmation email?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 17:31:28 評論於
Hello, do all authors need to click that confirmation email to verify the manuscript?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 17:08:50 評論於
Hello, do all authors need to click on the manuscript confirmation email?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 16:35:08 評論於
Hello, do all authors need to click on the manuscript confirmation email?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 16:20:28 評論於
Hello, do all authors need to click on the manuscript confirmation email?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 10:15:49 評論於
Hello, do all authors need to click on the manuscript confirmation email?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 09:19:18 評論於
Hello, do all authors need to click on that confirmation email?
(0) 讚! | 俊艾小仙女

作者: 俊艾小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 08:33:57 評論於
Hello, do all authors need to click on that confirmation email for the manuscript?
(0) 讚! | 俊艾小仙女

作者: 晨风宵雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-01 16:28:05 評論於
I have withdrawn the manuscript
(0) 讚! | 晨风宵雨

作者: 晨风宵雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-28 14:55:16 評論於
No response... considering whether to withdraw the submission. It's never been this slow before, frustrating
(0) 讚! | 晨风宵雨

作者: 晨风宵雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-28 11:32:24 評論於
It's been half a year and I've reminded them twice, but I'm not sure if I should withdraw the submission
(0) 讚! | 晨风宵雨

作者: 云来淑惠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-24 23:51:13 評論於
I have also reminded multiple times
(0) 讚! | 云来淑惠

作者: 猫巷少女睿慈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-11 20:18:19 評論於
I've been under review for five months now. I've never seen a journal this slow. I've followed up once but received no response. Just followed up again. How is your submission doing?
(0) 讚! | 猫巷少女睿慈

作者: 猫巷少女睿慈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-10 23:41:22 評論於
This is the slowest journal I have ever seen in terms of review speed, and they don't even reply to reminders. At one point, I even suspected that I submitted to the wrong unknown journal. Please do not submit to this one
(0) 讚! | 猫巷少女睿慈

作者: Novia Tom


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-01 19:34:29 評論於
It has been a month since submission, and it has always been marked as "received by editor." Does this mean it hasn't been sent for external review yet?
(0) 讚! | Novia Tom

作者: 晨风宵雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-22 16:36:59 評論於
Review speed: 6.0 | Submission hit rate: 50.0
Experience sharing: Submitted on January 9th, still under review today (June 28th), reminded twice with no response. It will be even funnier if it gets rejected
(0) 讚! | 晨风宵雨

作者: 晨风宵雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-17 22:44:17 評論於
Have you sent it for external audit?
(0) 讚! | 晨风宵雨

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:14:47 評論於
Post hoc comparison refers to setting additional groups based on the characteristics of the data after data collection is completed, proposing research hypotheses, and conducting statistical analyses; it is the testing of non-research hypotheses and further exploratory analysis of the results
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:08:33 評論於
SPSS (Statistical Product and Service Solutions), "Statistical Product and Service Solutions"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:57:58 評論於
What is post-hoc testing?
(0) 讚! | 龙鳞孝礼

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 14:59:31 評論於
What statistical methods are generally used in typical situations?
(0) 讚! | 破戒阳平

作者: 雨巷少年意映


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-27 16:14:41 評論於
Review Speed: 1.0 Experience Sharing: On April 20, submitted a case series online, received an email the next day stating it did not meet the requirements of a case report with 2000 words and 10 references. Asked to revise and resubmit, clarified in email communication that it was a case series, not an individual case. Response indicated it could be resubmitted. Submitted on 4.22, rejected on 4.28, feedback stated that the submission did not receive a high enough priority rating to warrant publication. Provided suggestion to transfer to Medicine, a journal under Wolters Kluwer Health with an impact factor of around 1.6-1.8. Likely due to low quality of the article, response was extremely fast, results communicated within a week. Sharing for reference for fellow researchers
(0) 讚! | 雨巷少年意映

作者: 丹旋小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-04-08 09:49:02 評論於
Review Speed: 1.0 Experience Sharing: A clinical retrospective prognosis study of immune checkpoint inhibitors was submitted on March 27, 2020. Two days later it was under review, and the review was completed on April 7th. It was rejected on April 8th. Overall, the experience was not bad, as only one reviewer's comments were received, which seemed quite professional
(0) 讚! | 丹旋小郎君

作者: 天际代春


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-10 22:46:25 評論於
Review Speed: 3.0 Experience Sharing: I submitted for three months and then got rejected. It's really frustrating. Be careful where you submit!
(0) 讚! | 天际代春

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [JOURNAL OF IMMUNOTHERAPY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*